This review article examined the potential therapeutic role of melanocortin peptides, particularly KPV (a melanocortin receptor agonist), in promoting cutaneous wound healing through their anti-inflammatory and tissue-remodeling properties. The evidence level for this summary is a review article synthesizing existing literature rather than original clinical or experimental data. The review discusses how melanocortin peptides may modulate inflammatory responses and support various stages of wound healing, though clinical application remains investigational.